Two-Dimensional Nanosheet-Based Photonic Nanomedicine for Combined Gene and Photothermal Therapy.
2D nanosheet
black phosphorus
gene therapy
graphene oxide
photothermal therapy
translational metal dichalcogenide
Journal
Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923
Informations de publication
Date de publication:
2019
2019
Historique:
received:
30
10
2019
accepted:
04
12
2019
entrez:
11
2
2020
pubmed:
11
2
2020
medline:
11
2
2020
Statut:
epublish
Résumé
Two-dimensional (2D) nanosheets are characterized by their ultra-thin structure which sets them apart from their bulk materials. Due to this unique 2D structure, they have a high surface-to-volume ratio that can be beneficial for the delivery of various drugs including therapeutic DNAs and RNAs. In addition, various 2D materials exhibit excellent photothermal conversion efficiency when exposed to the near infrared (NIR) light. Therefore, this 2D nanosheet-based photonic nanomedicine has been gaining tremendous attention as both gene delivering vehicles and photothermal agents, which create synergistic effects in the treatment of different diseases. In this review, we briefly provide an overview of the following two parts regarding this type of photonic nanomedicine: (1) mechanism and advantages of nanosheets in gene delivery and photothermal therapy, respectively. (2) mechanism of synergistic effects in nanosheet-mediated combined gene and photothermal therapies and their examples in a few representative nanosheets (e.g., graphene oxide, black phosphorus, and translational metal dichalcogenide). We also expect to provide some deep insights into the possible opportunities associated with the emerging 2D nanosheets for synergistic nanomedicine research.
Identifiants
pubmed: 32038249
doi: 10.3389/fphar.2019.01573
pmc: PMC6985776
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
1573Informations de copyright
Copyright © 2020 Kim, Blake, De, Ouyang, Shi and Kong.
Références
Adv Healthc Mater. 2016 Nov;5(21):2776-2787
pubmed: 27717238
Biomaterials. 2015 Jan;39:206-17
pubmed: 25468372
J Control Release. 2016 Jun 10;231:17-28
pubmed: 26829099
Int J Biomater. 2018 Dec 9;2018:1539678
pubmed: 30627167
ACS Appl Mater Interfaces. 2018 Jun 27;10(25):21137-21148
pubmed: 29882656
Adv Drug Deliv Rev. 2016 Mar 1;98:99-112
pubmed: 26748259
Cold Spring Harb Perspect Biol. 2014 Sep 02;6(9):a016840
pubmed: 25183830
Angew Chem Int Ed Engl. 2018 Aug 6;57(32):10268-10272
pubmed: 29939484
Small. 2012 Aug 20;8(16):2577-84
pubmed: 22641430
Science. 2004 Oct 22;306(5696):666-9
pubmed: 15499015
ACS Appl Mater Interfaces. 2017 Feb 8;9(5):4509-4518
pubmed: 28106369
Small. 2013 Jun 10;9(11):1989-97
pubmed: 23292791
Sci Rep. 2018 Nov 6;8(1):16386
pubmed: 30401943
Plasmid. 2016 Mar-May;84-85:51-60
pubmed: 27072918
ACS Appl Mater Interfaces. 2019 Feb 13;11(6):6267-6275
pubmed: 30672683
Small. 2011 Jun 6;7(11):1569-78
pubmed: 21538871
Adv Drug Deliv Rev. 2011 Mar 18;63(3):136-51
pubmed: 20441782
Nanoscale. 2018 Sep 13;10(35):16365-16397
pubmed: 30151537
Angew Chem Int Ed Engl. 2017 Nov 13;56(46):14488-14493
pubmed: 28892587
Nat Plants. 2017 Jan 09;3:16207
pubmed: 28067898
Adv Healthc Mater. 2016 Aug;5(15):1918-30
pubmed: 27185583
Adv Mater. 2013 Mar 6;25(9):1353-9
pubmed: 23280690
Theranostics. 2018 Jan 1;8(4):1005-1026
pubmed: 29463996
Nanoscale Res Lett. 2014 Oct 27;9(1):587
pubmed: 25386104
Nanotheranostics. 2018 Aug 25;2(4):371-386
pubmed: 30324083
Anal Chem. 2019 Dec 3;91(23):15275-15283
pubmed: 31674180
Biochim Biophys Acta Gen Subj. 2017 Sep;1861(9):2334-2341
pubmed: 28689990
ACS Nano. 2011 Sep 27;5(9):7000-9
pubmed: 21815655
Nat Commun. 2018 Apr 12;9(1):1410
pubmed: 29650952
Nat Rev Cancer. 2017 Jan;17(1):20-37
pubmed: 27834398
J Control Release. 2011 May 10;151(3):220-8
pubmed: 21078351
Adv Sci (Weinh). 2018 Aug 16;5(10):1800510
pubmed: 30356942
Proc Natl Acad Sci U S A. 1995 Aug 1;92(16):7297-301
pubmed: 7638184
ACS Appl Mater Interfaces. 2012 Apr;4(4):2259-66
pubmed: 22409495
Theranostics. 2017 Feb 27;7(5):1133-1148
pubmed: 28435453
Adv Mater. 2017 Jan;29(1):
pubmed: 27797119
ACS Nano. 2014 Apr 22;8(4):3636-45
pubmed: 24580381
Angew Chem Int Ed Engl. 2019 Sep 16;58(38):13405-13410
pubmed: 31365775
Chem Soc Rev. 2014 Sep 7;43(17):6254-87
pubmed: 24811160
Science. 2013 Aug 30;341(6149):1230444
pubmed: 23990564
Chem Commun (Camb). 2018 Dec 11;54(99):13989-13992
pubmed: 30480683
Angew Chem Int Ed Engl. 2017 Sep 18;56(39):11896-11900
pubmed: 28640986
Biomater Sci. 2016 Dec 20;5(1):77-88
pubmed: 27822577
Small. 2014 Jan 15;10(1):117-26
pubmed: 23696272
ACS Nano. 2019 Jul 23;13(7):7750-7758
pubmed: 31244043
J Am Heart Assoc. 2012 Dec;1(6):e002568
pubmed: 23316318
J Control Release. 2010 Aug 3;145(3):182-95
pubmed: 20226220
Chem Commun (Camb). 2012 Sep 4;48(68):8496-8
pubmed: 22806440
Chem Commun (Camb). 2014 Nov 11;50(87):13338-41
pubmed: 25231502
Chem Commun (Camb). 2018 Mar 28;54(25):3142-3145
pubmed: 29527603
ACS Appl Mater Interfaces. 2017 Feb 22;9(7):5683-5691
pubmed: 28152314
Adv Mater. 2018 Jul 18;:e1803031
pubmed: 30019786
Chem Soc Rev. 2017 Jul 31;46(15):4400-4416
pubmed: 28722038
Adv Mater. 2018 Sep;30(38):e1802061
pubmed: 30043416
Nat Nanotechnol. 2014 May;9(5):372-7
pubmed: 24584274
Nature. 2003 Mar 6;422(6927):37-44
pubmed: 12621426
Adv Mater. 2016 Aug;28(29):6052-74
pubmed: 27105929
ACS Appl Mater Interfaces. 2018 Apr 18;10(15):12431-12440
pubmed: 29564897
Adv Mater. 2018 Apr;30(16):e1707389
pubmed: 29537662
Anal Chem. 2013 Jul 16;85(14):6775-82
pubmed: 23758346
Adv Healthc Mater. 2019 Jun;8(12):e1801655
pubmed: 30957991
Adv Sci (Weinh). 2019 Aug 20;6(19):1901211
pubmed: 31592423
ACS Appl Mater Interfaces. 2014 Aug 27;6(16):13697-706
pubmed: 24979758
ACS Nano. 2017 Oct 24;11(10):10135-10146
pubmed: 28985469
Int J Nanomedicine. 2016 May 05;11:1927-45
pubmed: 27226713
Chem Soc Rev. 2019 Jun 4;48(11):2891-2912
pubmed: 31120049
Small. 2016 Mar 2;12(9):1184-92
pubmed: 26389712
Angew Chem Int Ed Engl. 2016 Feb 5;55(6):2122-6
pubmed: 26710169